In contrast, tumors that arise from SOX2-negative lineages ectopically activate SOX2 during tumor progression, particularly in association with squamous transdifferentiation, but its functional contribution in these contexts appears variable or non-essential (40, 41, 42, 43, 44, 45, 46, 47). This evidence concerns the gene SOX2 and neoplasm.